CTNM
#3233
Contineum Therapeutics, Inc. - Common stock
14.6 3 USD
0.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.41%
Variación mensual
+18.94%
Variación en los últimos 6 meses
-4.19%
Cambio anual
-4.19%
Cierres anteriores
14.5 7
Open
14.6 3
Mínimo
14.6 3
High
14.6 3
Volumen
24
Financials
- Market Capitalization 337.94 M
- Employee 51
- Founded 2009
- CEO N/A
- Website www.contineum-tx.com
- Headquarter Delaware, United States
- FIGI BBG01M27SVP6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3212 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.99 USD | 0.00% | -0.33% | +58.20% | +164.60% | 348.51 M USD | ||
| 3225 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.78 USD | +0.21% | -1.24% | +35.41% | +243.88% | 340.27 M USD | ||
| 3236 |  HELP Cybin Inc. - Common Stock | 6.51 USD | -2.54% | +5.68% | +51.04% | -27.42% | 336.12 M USD | ||
| 3239 |  IMRX Immuneering Corporation - Class A Common Stock | 5.16 USD | -0.96% | -5.15% | +24.04% | +28.68% | 333.84 M USD |